Ounas Health raises €1M pre-seed round to build a new product category in clinical insights

Ounas Health Oy has closed a pre-seed funding round of approximately €1 million. The round was led by Superhero Capital, with additional participation from public funding sources.

Ounas Health is developing technology that transforms fragmented clinical data into actionable insights, helping make care more seamless for both healthcare professionals and patients. The company is focused particularly on the intersection of healthcare and eye care.

By combining data, technology, and clinical understanding, Ounas Health aims to establish a new category in digital health centered on comprehensive and usable clinical insights.

“We are building technology that turns fragmented health data into something that can be meaningfully used in clinical workflows. Our goal is to support better decision-making and improve the flow of care,” said Ville Wuotila, CEO & Co-Founder of Ounas Health.

“We were impressed by the strength of the founding team, their clear vision, and their ability to execute early on. Ounas Health is tackling a meaningful problem with a focused approach, and we believe they are well positioned to build something significant in this space,” said Juha Ruohonen, General Partner at Superhero Capital.

With the new funding, Ounas Health will focus on advancing its core technology, validating it in real clinical environments, and preparing for international growth.